2020
DOI: 10.21203/rs.3.rs-78155/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Prevalence and Distribution of Non – Tuberculous Mycobacteria (NTM) Among MDR-TB Suspected Patients in Northern Malawi

Abstract: BackgroundNon-tuberculosis Mycobacteria (NTM) are increasingly being recognized as human pathogens, causing substantial morbidity and mortality in progressive lung disease, immunosuppressed, the elderly and the youth. Similarity of clinical symptoms with MTB, coupled with limited diagnostic capacities in tuberculosis (TB) endemic developing countries has led to misdiagnosis of NTM pulmonary disease. The study aimed at establishing the prevalence and distribution of NTM among Multi-Drug Resistance Tuberculosis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Sub-Saharan African countries have the greatest burden of TB infections [55]. Pulmonary TB infections compromise the structural integrity of the lungs subsequently providing a suitable niche for NTM adherence and multiplication, hence the high number of NTM observed in MDR-TB cases [56]. A co-infection of TB and NTM could also be a possible occurrence in MTB-DR cases where the presence of NTM is attributed to its failure to respond to the first-line anti-TB drugs [57].…”
Section: Discussionmentioning
confidence: 99%
“…Sub-Saharan African countries have the greatest burden of TB infections [55]. Pulmonary TB infections compromise the structural integrity of the lungs subsequently providing a suitable niche for NTM adherence and multiplication, hence the high number of NTM observed in MDR-TB cases [56]. A co-infection of TB and NTM could also be a possible occurrence in MTB-DR cases where the presence of NTM is attributed to its failure to respond to the first-line anti-TB drugs [57].…”
Section: Discussionmentioning
confidence: 99%